Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Caregivers × Plasma cell × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 18 daratumumab 15 Cyclophosphamide 9 Calcium Dobesilate 7 Bortezomib 7 pomalidomide 6 carfilzomib 6 Lenalidomide 6 fludarabine 4 belantamab mafodotin 4 talquetamab 3 dexamethasone acetate 3 dexamethasone 21-phosphate 3 auricularum 3 Specimen Handling 3 Biopsy 3 isatuximab 2 Maintenance 2 Hyaluronoglucosaminidase 2 Exercise Therapy 2 Drug Therapy 2 CT103A chimeric antigen receptor 2 zanubrutinib 1 trametinib 1 selinexor 1 pembrolizumab 1 ixazomib 1 ibrutinib 1 iberdomide 1 fludarabine phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07276230 2025-12-29

ENTRAIDANT

Assistance Publique - Hôpitaux de Paris

Phase NA Not yet recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡